| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 7e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |